000142919 001__ 142919
000142919 005__ 20240229112535.0
000142919 0247_ $$2doi$$a10.1371/journal.pone.0210665
000142919 0247_ $$2pmid$$apmid:30657775
000142919 0247_ $$2pmc$$apmc:PMC6338368
000142919 0247_ $$2altmetric$$aaltmetric:54146986
000142919 037__ $$aDKFZ-2019-00547
000142919 041__ $$aeng
000142919 082__ $$a610
000142919 1001_ $$00000-0001-9494-9302$$aRobson, Jonathan P$$b0
000142919 245__ $$aIdentification of CD24 as a marker of Patched1 deleted medulloblastoma-initiating neural progenitor cells.l401
000142919 260__ $$aSan Francisco, California, US$$bPLOS$$c2019
000142919 3367_ $$2DRIVER$$aarticle
000142919 3367_ $$2DataCite$$aOutput Types/Journal article
000142919 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1614073493_19788
000142919 3367_ $$2BibTeX$$aARTICLE
000142919 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000142919 3367_ $$00$$2EndNote$$aJournal Article
000142919 520__ $$aHigh morbidity and mortality are common traits of malignant tumours and identification of the cells responsible is a focus of on-going research. Many studies are now reporting the use of antibodies specific to Clusters of Differentiation (CD) cell surface antigens to identify tumour-initiating cell (TIC) populations in neural tumours. Medulloblastoma is one of the most common malignant brain tumours in children and despite a considerable amount of research investigating this tumour, the identity of the TICs, and the means by which such cells can be targeted remain largely unknown. Current prognostication and stratification of medulloblastoma using clinical factors, histology and genetic profiling have classified this tumour into four main subgroups: WNT, Sonic hedgehog (SHH), Group 3 and Group 4. Of these subgroups, SHH remains one of the most studied tumour groups due to the ability to model medulloblastoma formation through targeted deletion of the Shh pathway inhibitor Patched1 (Ptch1). Here we sought to utilise CD antibody expression to identify and isolate TIC populations in Ptch1 deleted medulloblastoma, and determine if these antibodies can help classify the identity of human medulloblastoma subgroups. Using a fluorescence-activated cell sorted (FACS) CD antibody panel, we identified CD24 as a marker of TICs in Ptch1 deleted medulloblastoma. CD24 expression was not correlated with markers of astrocytes or oligodendrocytes, but co-labelled with markers of neural progenitor cells. In conjunction with CD15, proliferating CD24+/CD15+ granule cell precursors (GCPs) were identified as a TIC population in Ptch1 deleted medulloblastoma. On human medulloblastoma, CD24 was found to be highly expressed on Group 3, Group 4 and SHH subgroups compared with the WNT subgroup, which was predominantly positive for CD15, suggesting CD24 is an important marker of non-WNT medulloblastoma initiating cells and a potential therapeutic target in human medulloblastoma. This study reports the use of CD24 and CD15 to isolate a GCP-like TIC population in Ptch1 deleted medulloblastoma, and suggests CD24 expression as a marker to help stratify human WNT tumours from other medulloblastoma subgroups.
000142919 536__ $$0G:(DE-HGF)POF3-312$$a312 - Functional and structural genomics (POF3-312)$$cPOF3-312$$fPOF III$$x0
000142919 588__ $$aDataset connected to CrossRef, PubMed,
000142919 7001_ $$0P:(DE-He78)a244aa021112b9002419791434bbc71c$$aRemke, Marc$$b1$$udkfz
000142919 7001_ $$0P:(DE-He78)4c28e2aade5f44d8eca9dd8e97638ec8$$aKool, Marcel$$b2$$udkfz
000142919 7001_ $$aJulian, Elaine$$b3
000142919 7001_ $$0P:(DE-He78)8d9c904a6cea14d4c99c78ba46e41f93$$aKorshunov, Andrey$$b4$$udkfz
000142919 7001_ $$0P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9$$aPfister, Stefan$$b5$$udkfz
000142919 7001_ $$aOsborne, Geoffrey W$$b6
000142919 7001_ $$aTaylor, Michael D$$b7
000142919 7001_ $$aWainwright, Brandon$$b8
000142919 7001_ $$aReynolds, Brent A$$b9
000142919 773__ $$0PERI:(DE-600)2267670-3$$a10.1371/journal.pone.0210665$$gVol. 14, no. 1, p. e0210665 -$$n1$$pe0210665 -$$tPLOS ONE$$v14$$x1932-6203$$y2019
000142919 909CO $$ooai:inrepo02.dkfz.de:142919$$pVDB
000142919 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a244aa021112b9002419791434bbc71c$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000142919 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)4c28e2aade5f44d8eca9dd8e97638ec8$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000142919 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)8d9c904a6cea14d4c99c78ba46e41f93$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000142919 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9$$aDeutsches Krebsforschungszentrum$$b5$$kDKFZ
000142919 9131_ $$0G:(DE-HGF)POF3-312$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vFunctional and structural genomics$$x0
000142919 9141_ $$y2019
000142919 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bPLOS ONE : 2017
000142919 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000142919 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000142919 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000142919 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central
000142919 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal
000142919 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ
000142919 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Peer review
000142919 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ
000142919 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000142919 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000142919 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000142919 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000142919 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000142919 915__ $$0StatID:(DE-HGF)1040$$2StatID$$aDBCoverage$$bZoological Record
000142919 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000142919 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000142919 9201_ $$0I:(DE-He78)L401-20160331$$kL401$$lDKTK Essen$$x0
000142919 9201_ $$0I:(DE-He78)B062-20160331$$kB062$$lB062 Pädiatrische Neuroonkologie$$x1
000142919 9201_ $$0I:(DE-He78)B300-20160331$$kB300$$lKKE Neuropathologie$$x2
000142919 980__ $$ajournal
000142919 980__ $$aVDB
000142919 980__ $$aI:(DE-He78)L401-20160331
000142919 980__ $$aI:(DE-He78)B062-20160331
000142919 980__ $$aI:(DE-He78)B300-20160331
000142919 980__ $$aUNRESTRICTED